A Study on the Effect of Glucagon Like Peptide 1 Agonist on Glycemic State, Renal Functions and Some Hemodynamic Parameters in Diabetic Male Albino Rats

Potential Reno-protective Influence of Canagliflozin in Male Albino Rats with Metabolic Syndrome

THE POTENTIAL MODULATING IMPACT OF THE DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITOR, SITAGLIPTIN ON STREPTOZOTOCIN-NICOTINAMIDE-INDUCED DIABETIC NEPHROPATHY IN RATS

Assessment of SGLT2 Inhibitor, Canagliflozin Effects on Metabolic Syndrome-Induced Cardiovascular Disorders in Rats

SERUM ADROPIN LEVEL AND KIDNEY FUNCTIONS IN TYPE-II DIABETIC RAT MODEL WITH AND WITHOUT PIOGLITAZONE TREATMENT

Experimental Rat Model of Diabetic Nephropathy: RAGE Detection and Effect of Spironolactone Monotherapy

ROLE OF THIAZOLIDINEDIONES (TZDs) AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS AND ANTAGONOSTS IN TYPE-II DIABETES MELLITUS ON ADULT MALE ALBINO RATS

EFFECTS OF TRIMETAZIDINE ON OXIDATIVE STRESS IN STREPTOZOTOCIN-INDUCED DIABETIC NEPHROPATHY IN RATS

COMPARATIVE GLUCOSE-LOWERING AND RENOPROTECTIVE EFFECTS OF SITAGLIPTIN AND INSULIN AND THEIR COMBINED THERAPY ON TYPE-2 DIABETES MELLITUS WITH NEPHROPATHY IN RATS

EFFECTS OF C -PEPTIDE AND GLUCAGON-LIKE PEPTIDE-1 ON DIABETIC MALE ALBINO RATS WITH AND WITHOUT ANTIOXIDANTS